Ruffino L - Search Results

1

Development of transgenic mice that inducibly express an active form of c-Src in the epidermis.

Matsumoto T, Kiguchi K, Jiang J, Carbajal S, Ruffino L, Beltrán L, Wang XJ, Roop DR, DiGiovanni J. Matsumoto T, et al. Among authors: ruffino l. Mol Carcinog. 2004 Aug;40(4):189-200. doi: 10.1002/mc.20027. Mol Carcinog. 2004. PMID: 15264211

2

Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis.

Matsumoto T, Jiang J, Kiguchi K, Ruffino L, Carbajal S, Beltrán L, Bol DK, Rosenberg MP, DiGiovanni J. Matsumoto T, et al. Among authors: ruffino l. Cancer Res. 2003 Aug 15;63(16):4819-28. Cancer Res. 2003. PMID: 12941801

3

Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma.

Kiguchi K, Carbajal S, Chan K, Beltrán L, Ruffino L, Shen J, Matsumoto T, Yoshimi N, DiGiovanni J. Kiguchi K, et al. Among authors: ruffino l. Cancer Res. 2001 Oct 1;61(19):6971-6. Cancer Res. 2001. PMID: 11585718

4

Chemopreventive and therapeutic efficacy of orally active tyrosine kinase inhibitors in a transgenic mouse model of gallbladder carcinoma.

Kiguchi K, Ruffino L, Kawamoto T, Ajiki T, Digiovanni J. Kiguchi K, et al. Among authors: ruffino l. Clin Cancer Res. 2005 Aug 1;11(15):5572-80. doi: 10.1158/1078-0432.CCR-04-2603. Clin Cancer Res. 2005. PMID: 16061875

5

Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model.

Wu Q, Kiguchi K, Kawamoto T, Ajiki T, Traag J, Carbajal S, Ruffino L, Thames H, Wistuba I, Thomas M, Vasquez KM, DiGiovanni J. Wu Q, et al. Among authors: ruffino l. Cancer Res. 2007 Apr 15;67(8):3794-800. doi: 10.1158/0008-5472.CAN-06-3214. Cancer Res. 2007. PMID: 17440093

6

Therapeutic effect of CS-706, a specific cyclooxygenase-2 inhibitor, on gallbladder carcinoma in BK5.ErbB-2 mice.

Kiguchi K, Ruffino L, Kawamoto T, Franco E, Kurakata S, Fujiwara K, Hanai M, Rumi M, DiGiovanni J. Kiguchi K, et al. Among authors: ruffino l. Mol Cancer Ther. 2007 Jun;6(6):1709-17. doi: 10.1158/1535-7163.MCT-07-0015. Mol Cancer Ther. 2007. PMID: 17575102

7

Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis.

Kiguchi K, Kitamura T, Moore T, Rumi M, Chang HC, Treece D, Ruffino L, Connolly K, DiGiovanni J. Kiguchi K, et al. Among authors: ruffino l. Cancer Prev Res (Phila). 2010 Aug;3(8):940-52. doi: 10.1158/1940-6207.CAPR-10-0010. Epub 2010 Aug 3. Cancer Prev Res (Phila). 2010. PMID: 20682802 Free PMC article.

8

The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice.

Kitamura T, Connolly K, Ruffino L, Ajiki T, Lueckgen A, DiGiovanni J, Kiguchi K. Kitamura T, et al. Among authors: ruffino l. J Hepatol. 2012 Jul;57(1):84-91. doi: 10.1016/j.jhep.2012.01.018. Epub 2012 Feb 9. J Hepatol. 2012. PMID: 22326466 Free PMC article.

9

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.

Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, Bader AG. Wiggins JF, et al. Among authors: ruffino l. Cancer Res. 2010 Jul 15;70(14):5923-30. doi: 10.1158/0008-5472.CAN-10-0655. Epub 2010 Jun 22. Cancer Res. 2010. PMID: 20570894 Free PMC article.

10

Regression of murine lung tumors by the let-7 microRNA.

Trang P, Medina PP, Wiggins JF, Ruffino L, Kelnar K, Omotola M, Homer R, Brown D, Bader AG, Weidhaas JB, Slack FJ. Trang P, et al. Among authors: ruffino l. Oncogene. 2010 Mar 18;29(11):1580-7. doi: 10.1038/onc.2009.445. Epub 2009 Dec 7. Oncogene. 2010. PMID: 19966857 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters